You're reading the free version. Trader adds the live tape and alerts.
Start tracking
REGN Exercise Disclosure
Larosa Joseph J · SEC Form 4 · Filed Aug 21, 2026
Exercise
Calculated transaction value
$4.69M
Larosa Joseph J EVP General Counsel And Secret
REGN
Transaction date
Aug 19, 2026
Public filing date
Aug 21, 2026
Filing lag
Filed 2 days later
REGN daily price context
Close on/before transaction
$840.84
Aug 19, 2026
First close after public filing
$828.5
Aug 24, 2026
30-day return after filing
-3.66%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,282 shares @ $381.92
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001238303-26-000002
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$12.18M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN Current | Exercise | Aug 19, 2026 | $4.69M |
| Regeneron Pharmaceuticals, Inc. REGN | Disposition | Aug 19, 2026 | $7.49M |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Aug 19, 2026 | $0 |